Diagnosis & Disease Information

November 3, 2020

Evidence-based treatment guidelines for HCV infection from the expert panel of the AASLD and IDSA.

May 14, 2015

Guidelines for hepatitis B virus (HBV) screening among patients with cancer have been updated.

John Schieszer, MA

January 7, 2015

Recent results on entecavir may change use of lamivudine prophylaxis in cancer patients with the hepatitis B virus.

December 17, 2014

Risk of hepatitis B virus (HBV) related hepatitis and HBV reactivation is lower with entecavir and lamivudine in lymphoma.

December 2, 2014

To prevent reactivation, antiviral therapy recommended for chemotherapy, immunotherapy patients who are hepatitis B positive.

Leslie Burgess, MA

July 30, 2013

Immunotherapy targeting the CLTA4 protein in HCV-related HCC demonstrated modest extended survival in a disease that has a high mortality rate.

Next post in Gastrointestinal Cancers

Targeting Vascular Endothelial Growth Factor in Treatment of Hepatocellular Carcinoma